These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2059620)

  • 1. Redox enzyme engineering: conversion of human glutathione reductase into a trypanothione reductase.
    Bradley M; Bücheler US; Walsh CT
    Biochemistry; 1991 Jun; 30(25):6124-7. PubMed ID: 2059620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering the substrate specificity of glutathione reductase toward that of trypanothione reduction.
    Henderson GB; Murgolo NJ; Kuriyan J; Osapay K; Kominos D; Berry A; Scrutton NS; Hinchliffe NW; Perham RN; Cerami A
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8769-73. PubMed ID: 1924337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.
    Stoll VS; Simpson SJ; Krauth-Siegel RL; Walsh CT; Pai EF
    Biochemistry; 1997 May; 36(21):6437-47. PubMed ID: 9174360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of parasite trypanothione reductase: acquisition of glutathione reductase activity in a triple mutant.
    Sullivan FX; Sobolov SB; Bradley M; Walsh CT
    Biochemistry; 1991 Mar; 30(11):2761-7. PubMed ID: 2007114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular studies on trypanothione reductase: an antiparasitic target enzyme.
    Walsh C; Bradley M; Nadeau K
    Curr Top Cell Regul; 1992; 33():409-17. PubMed ID: 1354149
    [No Abstract]   [Full Text] [Related]  

  • 6. Active site of trypanothione reductase. A target for rational drug design.
    Hunter WN; Bailey S; Habash J; Harrop SJ; Helliwell JR; Aboagye-Kwarteng T; Smith K; Fairlamb AH
    J Mol Biol; 1992 Sep; 227(1):322-33. PubMed ID: 1522596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glutamyl binding site of trypanothione reductase from Crithidia fasciculata: enzyme kinetic properties of gamma-glutamyl-modified substrate analogues.
    el-Waer AF; Smith K; McKie JH; Benson T; Fairlamb AH; Douglas KT
    Biochim Biophys Acta; 1993 Nov; 1203(1):93-8. PubMed ID: 8105896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
    Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
    Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids.
    Fairlamb AH; Blackburn P; Ulrich P; Chait BT; Cerami A
    Science; 1985 Mar; 227(4693):1485-7. PubMed ID: 3883489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase.
    Borges A; Cunningham ML; Tovar J; Fairlamb AH
    Eur J Biochem; 1995 Mar; 228(3):745-52. PubMed ID: 7737173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The parasite-specific trypanothione metabolism of trypanosoma and leishmania.
    Krauth-Siegel RL; Meiering SK; Schmidt H
    Biol Chem; 2003 Apr; 384(4):539-49. PubMed ID: 12751784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanothione reductase of Trypanosoma congolense: gene isolation, primary sequence determination, and comparison to glutathione reductase.
    Shames SL; Kimmel BE; Peoples OP; Agabian N; Walsh CT
    Biochemistry; 1988 Jul; 27(14):5014-9. PubMed ID: 3167026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular studies on trypanothione reductase, a target for antiparasitic drugs.
    Walsh C; Bradley M; Nadeau K
    Trends Biochem Sci; 1991 Aug; 16(8):305-9. PubMed ID: 1957352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis(glutathionyl)spermine and other novel trypanothione analogues in Trypanosoma cruzi.
    Ariyanayagam MR; Oza SL; Mehlert A; Fairlamb AH
    J Biol Chem; 2003 Jul; 278(30):27612-9. PubMed ID: 12750367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution.
    Bailey S; Smith K; Fairlamb AH; Hunter WN
    Eur J Biochem; 1993 Apr; 213(1):67-75. PubMed ID: 8477734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design.
    Saravanamuthu A; Vickers TJ; Bond CS; Peterson MR; Hunter WN; Fairlamb AH
    J Biol Chem; 2004 Jul; 279(28):29493-500. PubMed ID: 15102853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of trypanothione synthetase from Trypanosoma brucei.
    Oza SL; Ariyanayagam MR; Aitcheson N; Fairlamb AH
    Mol Biochem Parasitol; 2003 Sep; 131(1):25-33. PubMed ID: 12967709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata.
    Henderson GB; Fairlamb AH; Ulrich P; Cerami A
    Biochemistry; 1987 Jun; 26(11):3023-7. PubMed ID: 3607007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of trypanothione reductase by substrate analogues.
    Garrard EA; Borman EC; Cook BN; Pike EJ; Alberg DG
    Org Lett; 2000 Nov; 2(23):3639-42. PubMed ID: 11073664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism.
    Krauth-Siegel RL; Comini MA
    Biochim Biophys Acta; 2008 Nov; 1780(11):1236-48. PubMed ID: 18395526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.